Article

marketwatch.com on 2019-04-19 18:06

FDA approves first generic naloxone nasal spray to treat opioid overdose

The Food and Drug Administration has given Israeli drugmaker Teva Pharmaceuticals Inc. final approval to market the first generic naloxone nasal spray ...

Related news